Lexicon Pharmaceuticals

  www.lexpharma.com
  www.lexpharma.com

Lexicon Pharmaceuticals Reviews

9 Reviews
3.5
9 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Lexicon Pharmaceuticals President, CEO, and Director Arthur T. Sands
Arthur T. Sands
5 Ratings
  1.  

    Work life balance and great culture within the office

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at Lexicon Pharmaceuticals

    Pros

    Benefits are better than most employers in the industry, and I have gained great knowledge and experience working with so many talented people

    Cons

    samll pharma company, right now there it is a bit risky until a deal is made.

    Advice to ManagementAdvice

    consider sharing a little more information with your employees on what is happening with deals, as there is too much speculation and to many rumors.

    Recommends
    Neutral Outlook
    No opinion of CEO

Lexicon Pharmaceuticals Interviews

Interview Experience

Interview Experience

50%
50%
0%

Getting an Interview

Getting an Interview

100%

Interview Difficulty

3.5
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Vivarium Interview

    Anonymous Interview Candidate in The Woodlands, TX
    Anonymous Interview Candidate in The Woodlands, TX
    Application Details

    I applied online. The process took a dayinterviewed at Lexicon Pharmaceuticals in December 2012.

    Interview Details

    Long procesd

    Interview Questions
    Negotiation Details
    Straight forward.
    Accepted Offer
    Positive Experience
    Difficult Interview

Lexicon Pharmaceuticals Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.lexpharma.com
Headquarters The Woodlands, TX
Size 150 to 499 Employees
Founded 1995
Type Company - Public (LXRX)
Industry Biotech & Pharmaceuticals
Revenue $1 to $5 million (USD) per year
Competitors Exelixis, Deltagen, Athersys

Lexicon Pharmaceuticals works with some of the biggest words in the dictionary -- words like deoxyribonucleic acid. The drug development company is focused on a handful of candidates in clinical and pre-clinical research, identified by its gene knockout technology. Its leading candidates include LX4211 for type 2 diabetes, LX1031and LX1033 for irritable bowel syndrome and LX1032 for carcinoid syndrome. Other products in its pipeline include treatments for rheumatoid arthritis and glaucoma. The company got its start with the development of knockout mice -- mice whose DNA... More

Work at Lexicon Pharmaceuticals? Share Your Experiences

Lexicon Pharmaceuticals

 
Click to Rate
or